FDA Inspection
Nexus Pharmaceuticals, LLCNexus Pharmaceuticals, LLC – FDA Inspection, May 25, 2022
Record Details
This FDA Inspection record concerns Nexus Pharmaceuticals, LLC, with an inspection on May 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nexus Pharmaceuticals, LLC
- Inspection Date
- May 25, 2022
- Product Type
- Drugs
View Company Profile
ID · d820ab6f-59c0-4bda-89aa-27937437a5f9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1171206
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Nexus Pharmaceuticals, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | VAI | Chicago District Office | Drug Quality Assurance |
| November 7, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nexus Pharmaceuticals, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.